DPI 894
Pill imprint DPI 894 has been identified as Guaifenesin and pseudoephedrine 250 mg / 120 mg.
Guaifenesin/pseudoephedrine is used in the treatment of cough and nasal congestion and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy.
Guaifenesin/pseudoephedrine 250 mg / 120 mg is not subject to the Controlled Substances Act.
See also related documents.
Guaifenesin and pseudoephedrine Images
- Imprint:
-
DPI
894 - Strength:
- 250 mg / 120 mg
- Color:
- White / Clear
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Duramed Pharmaceuticals, Inc.
Advertisement
More Guaifenesin and Pseudoephedrine resources
- Guaifenesin/Pseudoephedrine (Wolters Kluwer)
- Guaifenesin/Pseudoephedrine Capsules (Wolters Kluwer)
- Guaifenesin/Pseudoephedrine Controlled-Release Capsules (Wolters Kluwer)
- Guaifenesin/Pseudoephedrine Liquid (Wolters Kluwer)
- Guaifenesin/Pseudoephedrine Sustained-Release Tablets (Wolters Kluwer)
- Triaminic Chest/Nasal Liquid (Wolters Kluwer)
- Triaminic Softchews Chest Congestion (Cerner Multum)
- guaifenesin and pseudoephedrine (Cerner Multum)
- Mucinex D Maximum Strength (FDA)
Search Again
